Skip to main content
Table of Contents
Print

Are there any risks associated with using cannabis for migraines? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

While many people report positive results, it’s important to consider the risks of cannabis for migraines  before using it as a treatment option. Like any medication or therapy, cannabis affects individuals differently, and what works well for one person may cause unwanted effects in another. 

As interest in cannabis-based migraine relief grows, so too does the need for balanced information. Understanding the risks of cannabis for migraines helps ensure safer and more informed decisions, especially when used regularly or alongside other treatments. 

Possible Risks and Considerations 

Below are some potential concerns to keep in mind when evaluating cannabis as a treatment option. 

Cognitive side effects 

Some users experience brain fog, memory lapses, or reduced concentration, especially with THC-rich strains. These are among the common cannabis side effects for migraine. 

Dependency or overuse 

Regular use may lead to tolerance or psychological dependence in some individuals. It’s essential to use cannabis mindfully, especially when self-medicating. 

Triggering rebound headaches 

Overuse of any migraine treatment can lead to medication overuse headaches. Cannabis may contribute to this if not monitored carefully, raising concerns about cannabis for migraine safety. 

Legal and workplace implications 

Depending on your location, cannabis use may be restricted or impact employment. Understanding the legal status is vital before starting treatment. 

While cannabis offers relief for many, acknowledging the risks of cannabis for migraines ensures that individuals approach it with the right knowledge and care. Always consider both the potential benefits and the cannabis as migraine treatment and its risks before making it part of your routine. 

If you’re exploring cannabis treatment options for migraines, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and migraines. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories